Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
SLS
↓ PDF (Pro)SELLAS Life Sciences Group Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$5.13
+5.24%today
MKT CAP
$946M
+6.2% · 1Y
Earnings History
+34.4%
+8.7%
+21.7%
+21.0%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$5.13
Low
$10.00
Analyst Mean
$10.00
High
$10.00
2 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-30.8x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership0.4%
Institutional Ownership20.4%
Short % of Float30.83%
Days to Cover8.3d
1 Week+2.3%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| VARIAN JOHN W | Director | Stock | 50,000 | $0.00 | $0.00M | 2026-01-07 |
| VAN NOSTRAND ROBERT L | Director | Stock | 50,000 | $0.00 | $0.00M | 2026-01-07 |
| SCHEINBERG DAVID A | Director | Stock | 50,000 | $0.00 | $0.00M | 2026-01-07 |
| WASMAN JANE | Director | Stock | 50,000 | $0.00 | $0.00M | 2026-01-07 |
| CICIC DRAGAN | Officer | Stock | 300,000 | $0.00 | $0.00M | 2026-01-07 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Vanguard Group Inc | institution | 4.59% | $0.04B | +23.79% | 2025-12-31 |
| Blackrock Inc. | institution | 4.09% | $0.04B | +32.60% | 2025-12-31 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | fund | 2.66% | $0.03B | +100.00% | 2026-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.43% | $0.02B | +19.17% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 2.25% | $0.02B | +35.49% | 2026-03-31 |
| Geode Capital Management, LLC | institution | 1.67% | $0.02B | +35.90% | 2025-12-31 |
| State Street Corporation | institution | 1.19% | $0.01B | +60.79% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.85% | $0.01B | +43.27% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 Growth ETF | fund | 0.76% | $0.01B | +35.80% | 2026-03-31 |
| Millennium Management Llc | institution | 0.75% | $0.01B | +341.00% | 2025-12-31 |
| Marshall Wace LLP | institution | 0.73% | $0.01B | -43.14% | 2025-12-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | fund | 0.66% | $0.01B | +0.97% | 2026-02-28 |
| Two Sigma Investments, LP | institution | 0.59% | $0.01B | +641.97% | 2025-12-31 |
| Dagco, Inc. | institution | 0.56% | $0.01B | +78.13% | 2026-03-31 |
| Northern Trust Corporation | institution | 0.50% | $0.00B | +27.30% | 2025-12-31 |
| Morgan Stanley | institution | 0.48% | $0.00B | -15.54% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.40% | $0.00B | -0.36% | 2026-02-28 |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | fund | 0.33% | $0.00B | +24.73% | 2026-02-28 |
| VANGUARD WELLINGTON FUND-Vanguard U.S. Momentum Factor ETF | fund | 0.24% | $0.00B | -12.65% | 2026-02-28 |
| iShares Trust-iShares Micro-Cap ETF | fund | 0.23% | $0.00B | +31.59% | 2026-03-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for SLS.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.